Detail of the clinical trial

Title of the trial Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients
EudraCT number 2013-005157-75
Protocol number EMN12/HO129
Sponsor Stichting Hemato-Oncologie voor Volwassenen Nederland (Hovon), De Boelelaan 1117, PK 5X181, 1081 HV Amsterdam, Netherlands
Indications Hemato-oncology
Diagnosis Primary plasma cell leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2018
Date of approval by Institute (SÚKL) 25.10.2018
Date of approval by EC
Date of initiation CT in ČR 10.9.2019
Date of ending CT in ČR
Sites Fakultní nemocnice Hradec Králové,IV. interní hematologická klinika,Sokolská 581,Hradec Králové,50005
Fakultní nemocnice Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,62500
Fakultní nemocnice Ostrava,Klinika hematoonkologie,17.Listopadu 1790,Ostrava,70852

‹‹ Back to list